Evidence map›Paper›PMID 29297379›Full record

ArticleJournal of biomedical semantics2017

Constructing an integrated gene similarity network for the identification of disease genes.

Zhen Tian, Maozu Guo, Chunyu Wang, LinLin Xing, Lei Wang, Yin Zhang

Abstract read
In one paragraph

Article in Journal of biomedical semantics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Multi-modal intermediate integrative methods in neuropsychiatric disorders: A review.Computational and structural biotechnology journal · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhen TianSchool of Computer Science and Engineering, Harbin Institute of Technology, Harbin, 150001, People's Republic of China.
Maozu GuoSchool of Computer Science and Engineering, Harbin Institute of Technology, Harbin, 150001, People's Republic of China. maozuguo@hit.edu.cn.
Chunyu WangSchool of Computer Science and Engineering, Harbin Institute of Technology, Harbin, 150001, People's Republic of China.
LinLin XingSchool of Computer Science and Engineering, Harbin Institute of Technology, Harbin, 150001, People's Republic of China.
Lei WangInstitute of Health Service and Medical Information Academy of Military Medical Sciences Beijing, Beijing, 100850, China.
Yin ZhangInstitute of Health Service and Medical Information Academy of Military Medical Sciences Beijing, Beijing, 100850, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiscovering novel genes that are involved human diseases is a challenging task in biomedical research. In recent years, several computational approaches have been proposed to prioritize candidate disease genes. Most of these methods are mainly based on protein-protein interaction (PPI) networks. However, since these PPI networks contain false positives and only cover less half of known human genes, their reliability and coverage are very low. Therefore, it is highly necessary to fuse multiple genomic data to construct a credible gene similarity network and then infer disease genes on the whole genomic scale.

resultsWe proposed a novel method, named RWRB, to infer causal genes of interested diseases. First, we construct five individual gene (protein) similarity networks based on multiple genomic data of human genes. Then, an integrated gene similarity network (IGSN) is reconstructed based on similarity network fusion (SNF) method. Finally, we employee the random walk with restart algorithm on the phenotype-gene bilayer network, which combines phenotype similarity network, IGSN as well as phenotype-gene association network, to prioritize candidate disease genes. We investigate the effectiveness of RWRB through leave-one-out cross-validation methods in inferring phenotype-gene relationships. Results show that RWRB is more accurate than state-of-the-art methods on most evaluation metrics. Further analysis shows that the success of RWRB is benefited from IGSN which has a wider coverage and higher reliability comparing with current PPI networks. Moreover, we conduct a comprehensive case study for Alzheimer's disease and predict some novel disease genes that supported by literature.

conclusionsRWRB is an effective and reliable algorithm in prioritizing candidate disease genes on the genomic scale. Software and supplementary information are available at http://nclab.hit.edu.cn/~tianzhen/RWRB/ .

Indexed as

AlgorithmsGene Regulatory NetworksComputational BiologyDiseaseGene OntologyHumansMolecular Sequence AnnotationDisease gene identificationGene OntologyGene similarity networksSimilarity network fusion

Identifiers

PMID29297379
PMCPMC5763299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.